Page last updated: 2024-08-25

atovaquone and HIV Coinfection

atovaquone has been researched along with HIV Coinfection in 29 studies

Research

Studies (29)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (41.38)	18.2507
2000's	8 (27.59)	29.6817
2010's	8 (27.59)	24.3611
2020's	1 (3.45)	2.80

Authors

Authors	Studies
Camara, L; Queirós, J; Ribeiro, R; Teófilo, E	1
Booth, J; Chowdary, P; Khurram, MA; Mohamed, IH; Shetty, S; Yaqoob, M	1
Beckerich, F; Cordonnier, C; Hulin, A; Khoudour, N; Lê, MP; Leclerc, M; Massias, L; Maury, S; Melica, G; Redjoul, R; Robin, C	1
Alkhuja, S; Gandotra, SD; Magge, T; Smotrys, M	1
Ehrhardt, J; Frank, M; Kremsner, P; Trein, A	1
Alfaro, RM; Calderón, MM; Kovacs, JA; Kumar, P; McManus, M; Pau, AK; Penzak, SR	1
Ball, SC; O'Neal, CB	1
Bellamy, RJ	1
Burger, DM; Faraj, D; Gelinck, L; Kroon, F; Kuks, PF; Richter, C; Van der Ende, ME; Van der Ven, A; van Luin, M; Van Schaik, RH; Visser, M; Wit, FW	1
Bellagamba, R; D'Avolio, A; Gallo, AL; Ivanovic, J; Narciso, P; Nicastri, E; Pucillo, LP; Tempestilli, M; Tommasi, C	1
Lewthwaite, P; Uriel, A	1
James, CW; McNelis, KC; Szabo, S	1
Dankner, WM; Flores, MA; Huang, S; Hughes, WT; Kline, MW; Paul, ME; Wei, LJ; Yogev, R	1
Bellamy, R	3
Nüesch, R	1
Bouboulis, DA; Frieri, M; Madden, J; Rubinstein, A; Shliozberg, J	1
Meyer, C	1
Chambers, HF; Goldstein, D; Lee, BL; Sadler, B; Täuber, MG	1
Holmberg, SD; Moorman, AC; Palella, FJ; Von Bargen, JC	1
Bryan, E; McFarland, J; Sackoff, J; Su, S	1
Balfour, HH; Cheung, TW; El-Sadr, WM; Eng, R; Hafner, R; Hooton, TM; Kerkering, TM; Luskin-Hawk, R; Murphy, RL; Schutz, M; van der Horst, C; Yurik, TM	1
Horowitz, HW; Wormser, GP	1
Caldwell, P; Chan, C; Dohn, M; Lefebvre, EA; Marina, R; McIvor, RA; Montaner, J; Morey, G; Scott, J	1
Chaloner, K; Rhame, FS	1
Hughes, WT	1
Flynn, PM; Fullen, G; Hetherington, SV; Hughes, WT; Kennedy, W; Lancaster, DJ; Palte, S; Rosenbaum, D; Shenep, JL; Stein, DS	1

Reviews

5 review(s) available for atovaquone and HIV Coinfection

Article	Year
Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2 Topics: Adult; Anti-Bacterial Agents; Anti-HIV Agents; Atovaquone; CD4 Lymphocyte Count; CD4-CD8 Ratio; COVID-19; Dideoxynucleosides; Female; Glucocorticoids; Graft Rejection; HIV Infections; HIV-1; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Middle Aged; Mycophenolic Acid; Pneumonia, Pneumocystis; Prednisolone; Raltegravir Potassium; RNA, Viral; SARS-CoV-2; Tacrolimus; Trimethoprim, Sulfamethoxazole Drug Combination	2021
HIV: treating Pneumocystis pneumonia (PCP). BMJ clinical evidence, 2008, Jul-16, Volume: 2008 Topics: Administration, Oral; Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Atovaquone; HIV Infections; Humans; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	2008
Pneumocystis carinii pneumonia treatment in people infected with HIV. Clinical evidence, 2004, Issue:11 Topics: Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination	2004
Pneumocystis pneumonia in people with HIV. Clinical evidence, 2005, Issue:13 Topics: Atovaquone; Clindamycin; Corticosterone; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination	2005
Pneumocystis pneumonia in people with HIV. Clinical evidence, 2006, Issue:15 Topics: Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	2006

Trials

7 trial(s) available for atovaquone and HIV Coinfection

Article	Year
Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Apr-15, Volume: 62, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Infective Agents; Atazanavir Sulfate; Atovaquone; Benzoxazines; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Encephalitis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Reverse Transcriptase Inhibitors; Ritonavir; Toxoplasmosis, Cerebral; Young Adult	2016
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jan-01, Volume: 40, Issue:1 Topics: Adolescent; AIDS-Related Opportunistic Infections; Atovaquone; Azithromycin; Bacterial Infections; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Male; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	2005
Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine. Clinical pharmacology and therapeutics, 1996, Volume: 59, Issue:1 Topics: Adult; Analysis of Variance; Antiviral Agents; Atovaquone; Cross-Over Studies; Glucuronates; HIV Infections; Humans; Male; Middle Aged; Naphthoquinones; Zidovudine	1996
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Dec-01, Volume: 19, Issue:4 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Dapsone; Ethnicity; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medical Records; Mycobacterium avium-intracellulare Infection; Naphthoquinones; New York City; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Regression Analysis; Rifabutin; Risk-Taking; Time Factors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Public Health Service	1998
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Grou The New England journal of medicine, 1998, Dec-24, Volume: 339, Issue:26 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Female; Follow-Up Studies; HIV Infections; Humans; Male; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	1998
Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. The Journal of infectious diseases, 1999, Volume: 180, Issue:2 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Sulfonamides; Trimethoprim	1999
Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. The Journal of infectious diseases, 1991, Volume: 163, Issue:4 Topics: Adult; Antifungal Agents; Atovaquone; Cohort Studies; Drug Evaluation; Drug Tolerance; Half-Life; HIV Infections; Homosexuality; Humans; Male; Naphthoquinones; Pneumonia, Pneumocystis	1991

Other Studies

17 other study(ies) available for atovaquone and HIV Coinfection

Article	Year
Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients. BMJ case reports, 2019, Dec-16, Volume: 12, Issue:12 Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome	2019
Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii. The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9 Topics: Aged; Antifungal Agents; Atovaquone; Biological Availability; Female; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis	2017
Babesiosis as a cause of false-positive HIV serology. BMJ case reports, 2018, Jun-08, Volume: 2018 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; HIV Infections; Humans; Male; Serologic Tests; Tick Bites; Treatment Outcome	2018
Plasmodium knowlesi and HIV co-infection in a German traveller to Thailand. Malaria journal, 2013, Aug-13, Volume: 12 Topics: Antimalarials; Atovaquone; Coinfection; Drug Combinations; Germany; HIV Infections; Humans; Malaria; Male; Middle Aged; Plasmodium knowlesi; Proguanil; Thailand; Travel; Viral Load	2013
Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection. The AIDS reader, 2008, Volume: 18, Issue:10 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atovaquone; Female; HIV; HIV Infections; Humans; Immunohistochemistry; Pentamidine; Pneumocystis carinii; Pneumocystis Infections; Polymerase Chain Reaction; Spleen; Splenic Diseases; Trimethoprim, Sulfamethoxazole Drug Combination	2008
Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir. AIDS (London, England), 2010, May-15, Volume: 24, Issue:8 Topics: Adolescent; Adult; Aged; Alkynes; Atazanavir Sulfate; Atovaquone; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Middle Aged; Oligopeptides; Proguanil; Pyridines; Pyrimidinones; Ritonavir; Young Adult	2010
Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis. Malaria journal, 2011, May-21, Volume: 10 Topics: Adult; Anti-HIV Agents; Antimalarials; Atovaquone; Chemoprevention; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Malaria; Nitriles; Plasma; Proguanil; Pyridazines; Pyrimidines; Saquinavir	2011
Malaria therapy in HIV: drug interactions between nevirapine and quinine. International journal of STD & AIDS, 2011, Volume: 22, Issue:12 Topics: Anti-HIV Agents; Antimalarials; Atovaquone; Drug Combinations; Drug Interactions; HIV Infections; Humans; Malaria, Falciparum; Male; Middle Aged; Nevirapine; Nigeria; Proguanil; Quinine; Travel; United Kingdom	2011
Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Aug-01, Volume: 60, Issue:15 Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Atovaquone; Clinical Protocols; Dapsone; Drug Therapy, Combination; HIV Infections; Hospital Administration; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Retreatment; Trimethoprim, Sulfamethoxazole Drug Combination	2003
[A case from practice (320). 1. Drug-induced fever. 2. HIV infection C3. multiple Kaposi sarcomas of the skin. Status after cerebral toxoplasmosis, PCP, herpes zoster. status after syphilis and gonorrhea]. Praxis, 1995, Mar-21, Volume: 84, Issue:12 Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Fever; HIV Infections; Humans; Male; Naphthoquinones	1995
Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1995, Volume: 74, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Child; Desensitization, Immunologic; Female; HIV Infections; Humans; Naphthoquinones; Pyrimethamine; Toxoplasmosis, Cerebral	1995
A banner year for AIDS therapy. The American journal of nursing, 1993, Volume: 93, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Atovaquone; HIV Infections; Humans; Itraconazole; Ketoconazole; Naphthoquinones; Rifabutin; Rifamycins; United States; United States Food and Drug Administration; Zalcitabine	1993
Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Oct-01, Volume: 19, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Morbidity; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Prospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; United States	1998
Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia. The New England journal of medicine, 1999, May-13, Volume: 340, Issue:19 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Drug Costs; HIV Infections; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1999
Quantifying and documenting prior beliefs in clinical trials. Statistics in medicine, 2001, Feb-28, Volume: 20, Issue:4 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Attitude of Health Personnel; Bayes Theorem; Clinical Trials as Topic; Dapsone; Ethics, Medical; HIV Infections; Humans; Naphthoquinones; Physicians; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; Sample Size; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination	2001
PCP prevention for children. Treatment review, 1995, Issue:no 18 Topics: Antifungal Agents; Atovaquone; Clinical Trials as Topic; Dapsone; HIV Infections; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination; United States	1995
A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia. Annals of internal medicine, 1992, Jun-01, Volume: 116, Issue:11 Topics: Antifungal Agents; Atovaquone; HIV Infections; Humans; Naphthoquinones; Opportunistic Infections; Pneumonia, Pneumocystis	1992